e-learning
resources
Vienna 2012
Monday, 03.09.2012
Mechanisms and modulation of allergic inflammation in the lung
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Poly:IC causes exacerbation in a murine allergic inflammation model driven by house dust mite in Freund‘s complete adjuvant
J. De Alba, R. Otal, E. Calama, F. Gil, N. Gozzard, M. Miralpeix (Barcelona, Spain; Slough, United Kingdom)
Source:
Annual Congress 2012 - Mechanisms and modulation of allergic inflammation in the lung
Session:
Mechanisms and modulation of allergic inflammation in the lung
Session type:
Thematic Poster Session
Number:
2326
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. De Alba, R. Otal, E. Calama, F. Gil, N. Gozzard, M. Miralpeix (Barcelona, Spain; Slough, United Kingdom). Poly:IC causes exacerbation in a murine allergic inflammation model driven by house dust mite in Freund‘s complete adjuvant. Eur Respir J 2012; 40: Suppl. 56, 2326
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Inflammatory and remodeling events in a murine model of asthma according to chronic exposure to house dust mite
Source: Eur Respir J 2007; 30: Suppl. 51, 368s
Year: 2007
The effect of BCG treatment on the remodelling in the house dust mite induced allergic asthma in mice
Source: Eur Respir J 2005; 26: Suppl. 49, 580s
Year: 2005
Calcaratarin D attenuates house dust mite-induced allergic asthma
Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science
Year: 2021
House dust mite induces direct airway inflammation in vivo: implications for future disease therapy?
Source: Eur Respir J 2010; 35: 1377-1387
Year: 2010
Assessment of the time course of chronic inflammation in the murine house dust mite model
Source: Annual Congress 2012 - Mechanisms and modulation of allergic inflammation in the lung
Year: 2012
Local lung house dust mite (HDM) challenges induce cell necrosis in mouse experimental asthma
Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD
Year: 2020
Oral presentation: Early sources of IL-13 in house dust mite-induced neonatal allergic airways disease
Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease
Year: 2013
LATE-BREAKING ABSTRACT: IRF3 is required for the induction of allergic airway inflammation by lung dendritic cells in a mouse model of house dust mite-induced atopic asthma
Source: Annual Congress 2009 - Models of chronic airways disease and therapy
Year: 2009
YS2: Role of Th9 cells in allergic airway inflammation induced by house dust mite
Source: Lung Science Conference 2011 - Immune system dysregulation in chronic lung disease
Year: 2011
Local and systemic inflammatory responses following bronchial instillation of house dust mite allergen (HDM) and HDM/lipopolysaccharide (LPS) in mild asthmatics
Source: Annual Congress 2011 - Mechanisms of allergic inflammation of the airways
Year: 2011
Do the current house dust mite-driven models really mimic allergic asthma?
Source: Eur Respir J 2010; 36: 1220-1221
Year: 2010
Local coagulation activation following bronchial instillation of house dust mite allergen (HDM) and HDM/Lipopolysaccharide (LPS) in mild asthmatics
Source: Annual Congress 2012 - Different ways to phenotype asthma
Year: 2012
Young Investigator session: Inhibition of airway hyperresponsiveness and inflammation by vaccination against IL-33 in a house dust mite model of asthma
Source: Lung Science Conference 2014 - Lung Inflammation and Immunity
Year: 2014
A house dust mite-induced asthma model in transcutaneously sensitized mice
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010
Monitoring spirometry-like parameters in mice with house dust mite-induced experimental asthma
Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease
Year: 2021
Effect of house dust mite sublingual immunotherapy on airway inflammation and remodeling in allergic asthma with rhinitis
Source: International Congress 2019 – Precision meets immunology in treatment of airway diseases
Year: 2019
Cigarette smoke exposure facilitates allergic sensitization to house dust mite and aggravates the asthmatic phenotype in mice
Source: Annual Congress 2012 - Mechanisms of asthma
Year: 2012
Allergyprotective effects of Staphylococcus scuiri in a house dust mite (HDM) model of allergic airway inflammation
Source: Annual Congress 2012 - Asthma: risk factors and effect of anti-IgE
Year: 2012
Correlation between nasal eosinophilic inflammation and bronchial reactivity to methacholine in allergic children sensitized to house dust mites (HDM)
Source: Eur Respir J 2002; 20: Suppl. 38, 172s
Year: 2002
Models to mimic allergic asthma using house dust mite or
Aspergillus fumigatus
in mice: advantages and disadvantages
Source: Annual Congress 2005 - PG11 - Experimental models for COPD and asthma
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept